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INTRODUCTION
Gastric carcinoma ranks second in cancer deaths
worldwide due to late presentation, poor treatment
options and aggressive disease course.1 Having
particularly high mortality rates in Asia, South America
and Central Europe, it is twice as common in males as
in females.2 There is great emphasis on early detection
of precancerous conditions because full blown carci-
noma has a depressing outlook.3 Studies in Pakistan
have also reported a high prevalence of gastric
carcinoma and its precancerous lesions but none as yet
reported prevalence of precancerous lesions with
special emphasis on patients of chronic gastritis.4,5
Gastric carcinogenesis is a multistep process with
intervening precancerous lesions, providing opportunity
to decrease mortality by halting this process and early
detection of stomach cancer.6,7 According to Correa's
model of carcinogenesis, gastric carcinogenesis is a
multistep process. The precancerous lesions implicated
in these steps are potentially reversible changes.3,6 So
the clinician should look for these lesions, as to detect
the abnormality at reversible stage rather than permitting
the lesions to become full blown cancer. Gastric
carcinoma pathogenesis is supposed to be the result
of a mixture of environmental factors, including
Helicobacter pylori (H. pylori) infection, excessive salt
intake, low vegetable and fruit intake and the
accumulation of specific genetic alterations.3,6 H. pylori
prevalence rate is high in Pakistan, India and
Bangladesh particularly in paediatric population. Once
acquired, this bacterium is able to establish lifelong
relationship with its host.7
The problem in the set-up is that gastric cancer is often
diagnosed at advanced stages leading to a very poor
prognosis.  Few centres put stress on early detection of
gastric carcinoma in potential candidates. An expanded
and long-term precancerous process, lasting for
decades, precedes most gastric cancers. It includes
the following sequential steps: chronic active gastritis,
multifocal atrophy, intestinal metaplasia, and intra-
epithelial neoplasia (dysplasia).5,7 An early diagnosis
and treatment of H. pylori infection with chronic gastritis
is a prudent investment and the goal of H. pylori
treatment is complete elimination of organism. This
includes triple therapy which combines two or more
antibiotics with an anti-secretory agent.8-10
Based on the frequency of precancerous lesions,
specific recommendations for obtaining biopsies in such
patients  can achieve an early detection of precancerous
gastric lesions and hence a favourable outcome through
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either treatment or prevention of progression of precan-
cerous lesions. 
The aim of this study was to determine the frequency of
precancerous changes in gastric biopsy specimens
obtained through endoscopy from patients having
chronic gastritis and dyspeptic symptoms for 6 months
who had not responded to targeted medical therapy.
METHODOLOGY
This prospective case series was conducted at Liaquat
National Hospital, Karachi, from July 2008 to January
2009. Specimens were collected by employing non-
probability purposive sampling technique. Sample size
was calculated as 375, at p = 58%, d = 5% and
confidence level = 95%. Patients belonging to either
gender, whose endoscopic gastric biopsies had been
received were enrolled after verbal informed consent
was taken. Duplicate samples from same patient or
samples from patients with a known carcinoma, ulcer,
polyp and pernicious anaemia or from patients on known
calcium antagonists, nitrates, theophyllines, bispho-
sphonates, corticosteroids and non-steroidal anti-
inflammatory drugs were excluded. All samples were
processed as per standard guidelines including steps of
fixation by 10% formalin, dehydration by increasing
concentration of ethyl alcohol (70%, 80% and 90%),
clearing by xylene and final preservation by paraffin
wax and then stained with routine Hematoxylin and
Eosin (H & E) stain for evaluation. Data was collected on
proforma including patient's demographics like age
and gender and by microscopic examination, presence
of activity, activity with Helicobacter pylori, atrophy,
metaplasia and dysplasia.
Data was stored in Statistical Package for Social
Sciences (SPSS) Windows version 10.0 statistical
package. To determine significance of any difference in
age between patients with and without the precancerous
conditions, T-test was used. To determine significance of
difference in gender between patients with and without
the precancerous conditions, Chi-square test was used.
P-value of less than 0.05 was considered significant;
95% confidence interval was computed for proportion of
specific precancerous lesion.
RESULTS
A total of 375 patients were included in this study
fulfilling the inclusion criteria. None of the biopsies was
inadequate for histopathological evaluation. Patients'
mean age was 41.3 ± 13.3 years ranging from 16 – 75
years. There was an equal distribution of gender seen.
Chronic active gastritis was encountered in most cases
(n = 181, 48.3%), strongly associated with the presence
of Helicobacter pylori organisms, where Helicobacter
pylori were seen in 175 (96.6%) biopsies out of the 181
cases of chronic active gastritis. Atrophy was present in
9.6% biopsies whereas intestinal metaplasia was found
in fewer number i.e. in 31 (8.3%) biopsies. Dysplasia,
which was the least common lesion, was present in only
5 (1.3%) patients. Some biopsies exhibited more than
one lesion. Precancerous lesions were found in 232
(61.9%) biopsies out of 375 biopsies. Mean (±SD) age of
precancerous positive patients was 42.2 ± 13.1 years
and precancerous negative patients was 39.7 (±13.6),
insignificant difference found to be p = 0.078, (min – max
= 16 – 65 years). Out of 232 positive cases, 160 (69%)
patients had age between 31 – 60 years. Gender
distribution of precancerous lesions was also noted and
the proportion of precancercous lesion positivity was
significantly higher in males (p = 0.003, Figure 1). Other
biopsy findings with respect to gender are shown in
Table I. Proportion of chronic active gastritis depicted by
activity was also significantly high in males. However,
proportion difference of atrophy was statistically
insignificant between gender, out of 36 cases, 20
(55.6%) were males and 16 (44.4%) were females.
Proportion of intestinal metaplasia in accordance with
gender was again significantly high in males. Among the
dysplasia cases, 3 (60%) were females and 2 (40%)
were males. Biopsy findings with respect to age groups
(i.e. ≤ 40 years and > 40 years) are detailed in Table II.
Proportion of chronic active gastritis was significantly
high in age group ≤ 40 years at p < 0.05. The percentage
of dysplasia was significantly high in age group > 40
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Figure 1: Gender distribution of precancercous lesions (n = 232).
Table I: Gender distribution of other biopsy findings in patients with 
chronic gastritis (n = 375).
Male Female p-values
Activity (chronic active gastritis) 103 (56.9%) 78 (43.1%) **0.0084+
Activity and Helicobacter pylori 98 (56.3%) 76 (43.7%) **0.0200
*At chi-square = 6.935 + Significant, **At chi-square = 5.411 +Significant.
Table II: Endoscopic gastric biopsies finding of chronic gastritis in age
(n = 375).
Age (years) < 40 Age (years) > 40 p-values*
Activity(Chronic active gastritis) 105 (58%) 76 (42%) **0.002+
Activity and Helicobacter pylori 101 (58%) 73 (42%) **0.002+
Dysplasia 0 5 (100%) 0.0617 n.s
Precancerous lesions in chornic gastritis
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years with all the cases of dysplasia having age more
than 40 years. The proportion of atrophy was again high
in age > 40 years, out of 36 cases, 33 (91.7%) cases
had age > 40 years while only 3 (8.3%) cases had age
≤ 40 years. Proportion of intestinal metaplasia was also
significantly high in age > 40 years, out of 31 biopsies,
28 (90.3%) cases had age > 40 years and only 3 (9.7%)
cases had ≤ 40 years.
DISCUSSION
Gastric cancer often presents at an advanced stage and
at that stage most patients have very short survival.18
The global incidence of gastric cancer is still quite high
with approximately 870,000 new cases and 650,000
deaths per year. The estimated current incidence of
gastric cancer is approximately 16.2/100,000 persons/
year.19 Gastric cancer in Karachi fall into the archetype
of a low risk developing country pattern, but increasing
incidence has been reported recently. This is most
marked in males above 40 years of age.20 The process
of carcinogenesis engages a slow but continuous
stepwise progression from active gastritis leading
to adenocarcinoma.21,18 Intestinal-type GC typically
arises in the setting of chronic active gastritis, usually
caused by Helicobacter pylori and develops through
intermediate stages.The chronic aggression to the
gastric epithelia eventually causes the appearance of
preneoplastic lesions and increases the risk of gastric
cancer. It has become evident that Helicobacter pylori
eradication by antibiotic treatment combined with proton
pump inhibitor (PPI) serves as the primary chemo-
prevention strategy to reduce gastric cancer incidence.
Moreover, the eradication therapy reduces gastric
cancer incidence in patients without any precancerous
lesions at the baseline and is most effective before the
development of atrophic gastritis.22
In this study, atrophic gastritis and intestinal metaplasia
were assessed separately, in conformity with the
updated Sydney system.23 In order to prevent
misclassification, the less advanced lesions that were
indefinite for dysplasia were classified as reactive atypia,
rather than dysplasia. In this study, the precancerous
lesions were seen more frequently in males. This
possibly represents same etiological factors (ecological,
genetic and life-style factors like smoking etc.) for
precancerous lesions and gastric carcinoma in males,
as the incidence of gastric carcinoma is also increasing
significantly in male population of Karachi.20 This may
be because some proposed causative factors for
premalignant lesions, such as smoking and tobacco use,
are more prevalent in males. In international studies,
frequency of precancerous lesions increases with
increasing age, however, precancerous lesions present
in patients over 60 years of age, was only 7.3% of total
in this study. The likely explanation for this is that out of
a total 375 biopsies, only 25 patients were more than 60
years of age, so the age distribution of precancerous
lesions could not reach statistical significance due to
small number of patients falling in that age group.
However, age is known as an important factor governing
the histological progression.3
The most common lesion was chronic active gastritis
and the additional significant finding of spiral bacterium
Helicobacter pylori signifies the chronic aggression by
H. pylori to the gastric mucosa which finally results in the
appearance of preneoplastic lesions and increases the
risk of gastric cancer.
In most of the other studies of this sort, patients with
symptoms of dyspepsia were selected, whereas, the
authors were more focused and wanted to be target
specific so that only those patients with symptoms of
dyspepsia were included that showed endoscopic
chronic gastritis. However, the present results were in
concordance with those seen in other international
studies, most probably because most patients with
symptoms of dyspepsia show signs of endoscopic
gastritis.24,25
Limitations of this study include confounders such as
biopsy sampling and focal nature of the precancerous
lesions which may alter results subject to sampling error.
The fact that the population in this study lived in a
relatively open society and had varying living conditions
or habits, may enhance the effects of other mixed factors
such as intake of fresh vegetables, salt consumption,
water intake. Unfortunately, the intra-gastric distribution
of pre-malignant lesions could not be evaluated in this
study because the data regarding the exact site of
biopsy and number of biopsies taken from each
compartment within the stomach was not available.
Therefore, for the evaluation of pre-malignant lesions, a
more extensive biopsy sampling may be required.
This study provides important insight into precancerous
lesions and that precancerous lesions are common in
patients with chronic gastritis. Helicobacter pylori
associated chronic active gastritis is the most common
pre-malignant gastric lesion. It can, therefore, be
assumed that all subsequent stages have a background
of chronic active inflammation of the gastric mucosa. It
was also found that advanced precancerous gastric
lesions increase with age (> 40 years) depicting age as
an important factor. In addition, there was gender
predilection and the lesions were more commonly seen
in males. It is recommended that gastric biopsy
histological evaluation should be done in all patients with
chronic gastritis. Follow-up and preventive strategies in
patients with established pre-malignant lesions is highly
recommended.
CONCLUSION
Precancerous lesions were encountered with significant
frequency in patients with endoscopic chronic gastritis.
Based on these findings, it is proposed that it is a
rational approach to get biopsies from patients with
endoscopic chronic gastritis, which can allow us to
detect precancerous lesions thus providing opportunity
to apply primary chemo-preventive strategies along with
lifestyle changes and halt initial steps of the gastric
carcinogenic cascade.   
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